BPA Call 36C25524A0025-36C25524N0203

Award Date 4/4/24
Potential Completion Date 3/27/25
Potential Value $747K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Millburn, NJ 07041, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for a Blanket Purchase Agreement (BPA) call with Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The contract is being administered by the Veterans Integrated Service Network 2, a civilian agency within the Department of Veterans Affairs (VA). The award is for the radiopharmaceutical product PLUVICTO (lutetium Lu 177 vipivotide tetraxetan), which is used for cancer...
This is a $3,987,496.80 firm-fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The contract is for the supply of PLUVICTO (Lutetium Lu 177 Vipivotide Tetraxetan), a radiopharmaceutical product used in cancer treatment and diagnostic imaging. The contract was awarded under the Pharmaceuticals and Drugs Federal Supply...
This federal contract award is for the provision of PLUVICTO (lutetium Lu 177 vipivotide tetraxetan), a radiopharmaceutical product used in targeted radioligand therapy and nuclear medicine procedures. The contract was awarded to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products, operating as a subsidiary of Novartis. The contract was awarded by the Department of Veterans Affairs (VA), specifically through...
This is a $2,476,989.38 delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceutical products. The contract is for the delivery of radiopharmaceuticals, including PLUVICTO, LUTATHERA, and other nuclear medicine products, to support diagnostic imaging, cancer treatment, and other medical applications at VA medical facilities. The contract is...
This is a $462,715.00 firm fixed price purchase order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Advanced Accelerator Applications USA Inc., a foreign-owned for-profit manufacturer of radiopharmaceuticals. The contract is for the delivery of various radiopharmaceutical products including Lutetium Lu 177 Dotatate, Lutetium Lu 177 Vipivotide Tetraxetan, gallium Ga 68 dotatate, and Ga-68 Dotatate injections to VA medical centers and integrated service...
This federal contract award to Advanced Accelerator Applications USA Inc., a foreign-owned manufacturer of radiopharmaceuticals, is for the supply of PLUVICTO (lutetium Lu 177 vipivotide tetraxetan) to the Defense Health Agency (DHA). The $481,664.50 firm fixed-price purchase order has an ultimate completion date of May 3, 2024. Advanced Accelerator Applications USA Inc. is a large, specialized manufacturer that holds several Indefinite Delivery Vehicles (IDVs) and Blanket Purchase Agreements...
This is a firm fixed-price contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network (VISN) 12 to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of goods. The contract is for the delivery of the radiopharmaceutical PLUVICTO from March to December 2023, with a potential value of $2,338,693.31. The contract was awarded under the Pharmaceuticals and Drugs Federal Supply Schedule...
This is a $187,035.70 firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Advanced Accelerator Applications USA Inc., a foreign-owned for-profit manufacturer of radiopharmaceutical products. The order is placed under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and provides Lutetium Lu 177 Dotatate, a radiopharmaceutical used in targeted radioligand therapy and nuclear medicine. Advanced Accelerator...
The U.S. Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) call contract to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The contract, with a total ceiling value of $993,272.70, is for the supply of Lutetium Lu 177 PLUVICTO 27mCi/mL, a radiopharmaceutical used for cancer treatment. This BPA call is under the parent Master GSA Schedule for Pharmaceuticals and Drugs...
This federal contract award is for the delivery of PLUVICTO and LUTATHERA radiopharmaceuticals to the Department of Veterans Affairs (VA). The contract, valued at $486,934.65, was awarded to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of specialized nuclear medicine products. The contract was awarded under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and is a Blanket Purchase Agreement (BPA) Call. This allows for the efficient...

This is a firm fixed price BPA call order awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 to Advanced Accelerator Applications USA Inc., a foreign-owned for-profit manufacturer of goods. The contract is for the delivery of the radiopharmaceutical product PLUVICTO (Lutetium Lu 177 Vipivotide Tetraxetan) with a potential value of $746,610.13 and a completion date of March 27, 2025.

Advanced Accelerator Applications USA Inc. is a radiopharmaceutical company that provides diagnostic and therapeutic radiopharmaceuticals to various federal agencies, including the VA, the Defense Health Agency, and the National Institutes of Health, through prime and subcontract awards. This contract was awarded through the Pharmaceuticals and Drugs Federal Supply Schedule (FSS 61-IB). The agency did not use a set-aside for this procurement.

Generated 4/5/24, 10:01 AM